Description

Volcano plots or differential metabolite analysis comparing dexamethasone-treated and control rat tissues. The chemical isotope labeling approach identifies significantly altered metabolites associated with glucocorticoid-induced perturbations.

Figure 12

Chart

Source Paper

Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical Isotope Labeling LC-MS analysis.

Metabolites (2020)

PMID: 31973046

DOI: 10.3390/metabo10020042

Cite This Figure

![Figure 12: Volcano plots or differential metabolite analysis comparing dexamethasone-treated and control rat tissues. The chemical isotope labeling approach identifies significantly altered metabolites associated with glucocorticoid-induced perturbations.]()

> Source: Lina A Dahabiyeh et al. "Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical ." *Metabolites*, 2020. PMID: [31973046](https://pubmed.ncbi.nlm.nih.gov/31973046/)

<figure>
  <img src="" alt="Volcano plots or differential metabolite analysis comparing dexamethasone-treated and control rat tissues. The chemical isotope labeling approach identifies significantly altered metabolites associated with glucocorticoid-induced perturbations." />
  <figcaption>Figure 12. Volcano plots or differential metabolite analysis comparing dexamethasone-treated and control rat tissues. The chemical isotope labeling approach identifies significantly altered metabolites associated with glucocorticoid-induced perturbations.<br>  Source: Lina A Dahabiyeh et al. "Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical ." <em>Metabolites</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31973046/">31973046</a></figcaption>
</figure>

Preuves associées

Uridine Monophosphate pour Neurotransmitter Imbalance

Note C · 4 études